Concomitant radiochemotherapy has become the standard treatment of local advanced nasopharyngeal carcinoma now.
目前同步放化疗已成为局部晚期鼻咽癌的标准治疗。
The main reason of treatment failure in local advanced nasopharyngeal carcinoma is distant metastasis and local recurrence.
局部晚期鼻咽癌治疗失败的主要原因为远处转移和局部复发。
Objective to observe the efficacy and toxicities of paclitaxel combined with DDP in treatment of advanced nasopharyngeal carcinoma.
目的观察紫杉醇联合顺铂治疗远处转移的晚期鼻咽癌的疗效和毒副反应。
Objective To analyse the effect of adjuvant chemotherapy combined radiotherapy of advanced nasopharyngeal carcinoma (N2, N3 stage).
目的分析评价晚期(N 2, N3期)鼻咽癌放疗加辅助化疗的疗效。
To evaluate the effect of combined radiotherapy and thymic peptide on the survival rate of moderate-advanced nasopharyngeal carcinoma.
探讨放疗联合胸腺肽治疗对中晚期鼻咽癌生存率的影响。
Objective: to observe the short-term efficacy in order to instruct the work about the advanced nasopharyngeal carcinoma (NPC) more effectively.
前言：目的：观察晚期鼻咽癌同期放化疗的近期疗效，以便更好地开展鼻咽癌的临床工作。
Objecti ve: To observe the short-term curative effects and the acute adverse effects of synchronous radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma.
目的：观察晚期鼻咽癌同步放、化疗近期疗效及急性不良反应。
Conclusions Physiological sea water of Bright Nose might be used as the effective means of preventing sinusitis for local advanced nasopharyngeal carcinoma after radiotherapy.
结论鼻朗生理性海水可作为预防局部晚期鼻咽癌放疗后鼻窦炎发生的有效手段。
Methods:Clinical data of 12 cases with local advanced nasopharyngeal carcinoma accepting induced chemotherapy plus concurrent chemotherapy and radiotherapy were analyzed retrospectively.
回顾性分析12例局部区域晚期鼻咽癌初治病人行诱导化疗加同期放化疗治疗的临床资料。
Objective: To observe the short-term curative effects, the survival rate of 3-year and the acute adverse effects of paclitaxel capsule combined with radiotherapy for advanced nasopharyngeal carcinoma.
目的：观察晚期鼻咽癌放疗并紫杉醇胶囊口服化疗的近期疗效、3年生存率及急性不良反应。
Objective: To observe the short-term curative effects, the survival rate of 3-year and the acute adverse effects of paclitaxel capsule combined with radiotherapy for advanced nasopharyngeal carcinoma.
目的：观察晚期鼻咽癌放疗并紫杉醇胶囊口服化疗的近期疗效、3年生存率及急性不良反应。
应用推荐